Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study

Mostrar otras versiones (1)

There are plausible mechanisms by which angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may increase the risk of COVID-19 infection or affect disease severity. To examine the association between these medications and COVID-19 infection or hospitalization, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Dublin, Sascha, Walker, Rod, Floyd, James S., Shortreed, Susan M., Fuller, Sharon, Albertson-Junkans, Ladia, Harrington, Laura B., Greenwood-Hickman, Mikael Anne, Green, Beverly B., Psaty, Bruce M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359535/
https://www.ncbi.nlm.nih.gov/pubmed/32676610
http://dx.doi.org/10.1101/2020.07.06.20120386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359535/
https://www.ncbi.nlm.nih.gov/pubmed/32676610
http://dx.doi.org/10.1101/2020.07.06.20120386

Ejemplares similares